Paul Tudor Jones's FLGT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 116,048 shares of Fulgent Genetics, Inc. (FLGT) worth $3.05 M, representing 0.01% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in FLGT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 137,399 shares. Largest reduction occurred in Q4 2025, reducing 55,447 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Fulgent Genetics (FLGT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Fulgent Genetics (FLGT) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -55,447 | Reduce 32.33% | 116,048 | $26.27 |
| Q3 2025 | -13,593 | Reduce 7.34% | 171,495 | $22.60 |
| Q2 2025 | +137,399 | Add 288.11% | 185,088 | $19.88 |
| Q1 2025 | +47,689 | New Buy | 47,689 | $16.90 |
| Q4 2024 | -17,018 | Sold Out | 0 | $0.00 |
| Q3 2024 | +17,018 | New Buy | 17,018 | $21.73 |
| Q1 2022 | -5,681 | Sold Out | 0 | $0.00 |
| Q4 2021 | +5,681 | New Buy | 5,681 | $100.51 |
| Q1 2021 | -10,069 | Sold Out | 0 | $0.00 |
| Q4 2020 | +10,069 | New Buy | 10,069 | $52.14 |
Paul Tudor Jones's Fulgent Genetics Investment FAQs
Paul Tudor Jones first purchased Fulgent Genetics, Inc. (FLGT) in Q4 2020, acquiring 10,069 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Fulgent Genetics, Inc. (FLGT) for 10 quarters since Q4 2020.
Paul Tudor Jones's largest addition to Fulgent Genetics, Inc. (FLGT) was in Q2 2025, adding 185,088 shares worth $3.68 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 116,048 shares of Fulgent Genetics, Inc. (FLGT), valued at approximately $3.05 M.
As of the Q4 2025 filing, Fulgent Genetics, Inc. (FLGT) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Fulgent Genetics, Inc. (FLGT) was 185,088 shares, as reported at the end of Q2 2025.